SCLN $1 Profitable NASDAQ drug stock next 3 bagger Biotech has been hottest area recently. SCLN is the cheapest profitable NASDAQ drug stock. -SCLN Turned profitable in Q3 2008. -In Monday PR they forecast $60 MM + sales in 2009 much of it to Booming China market. $1 per share working capital and no debt. Based on Monday February 9 PR which summarized total 2008 results, Q4 sales were $17 Million a blowout quarter. SCLN went to $8 a few years back and niw they are in better shape than ever.